May 2024

Doheny in the Spotlight at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting


As one of the world’s foremost vision research institutions, Doheny Eye Institute was well represented at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, held May 5-9 in Seattle. ARVO is the largest and most respected eye and vision research organization in the world.

Not only were Doheny scientists selected to present their latest research in more than 28 paper and poster presentations, but our own SriniVas Sadda, MD, was officially named president of ARVO at the conclusion of this year’s meeting. Additionally, multiple events and an engaging exhibitor presence helped Doheny connect with a wide variety of attendees. This year’s ARVO meeting welcomed more than 11,000 attendees.

The annual Doheny-UCLA Breakfast Forum on May 5 was a wonderful way to kick off the week, with a packed room of attendees to explore the topic of Fresh Perspectives on Retinopathy. Kaustabh Ghosh, PhD, helped organize and moderate this engaging discussion.

On May 6, Doheny reconnected with many of our esteemed alumni during the ARVO Annual Alumni Reception. The lively evening featured delectable food, drink, music, and conversation with friends old and new.

Throughout the exhibition portion of ARVO, Doheny and UCLA united once again in a shared booth space. Thousands of attendees visited to learn more about the institutes’ commitment to groundbreaking vision research, discuss opportunities to collaborate, and more.

One of the many highlights of the week included Chief Scientific Officer Deborah Ferrington, PhD, leading a mini-symposium session on her latest research in age-related macular degeneration. Other topics presented by Doheny scientists included diabetic retinopathy, advanced discoveries in neuro-ophthalmology, retinal cell biology and visual neuroscience.

The successful week concluded with Dr. Sadda, Director of Artificial Intelligence & Imaging Research at Doheny Eye Institute and Professor of Ophthalmology at the University of California – Los Angeles (UCLA), David Geffen School of Medicine, being officially introduced as president of ARVO. The moment came during the final keynote, marking the conclusion of the weeklong meeting.

Aside from a phenomenal and productive onsite presence, Doheny and our stellar scientists were also featured in several media articles coming out of ARVO 2024, including:

Now, all eyes are on ARVO 2025 in Salt Lake City, Utah, with planning efforts led by Dr. Sadda in his new role. It is sure to be another engaging and successful opportunity for Doheny to share our research, connect and collaborate with other top minds in our field.



Share this with your friends!